Furthermore, Src deficiency in both MEFs and breast cancer cells resulted in a decrease of various known APCCdh1 substrates (Fig. 6j–l and Supplementary Fig. 6j, k) without a significant impact on the cell cycle progression (Supplementary Fig. 6n, o). Here, SRC is linked to breast carcinoma.